
Vanessa L. Ford
Supervisory Patent Examiner (ID: 6966, Phone: (571)272-0857 , Office: P/1646 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1646, 1674 |
| Total Applications | 502 |
| Issued Applications | 154 |
| Pending Applications | 66 |
| Abandoned Applications | 291 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7230225
[patent_doc_number] => 20040156844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Tamper resistant oral dosage form'
[patent_app_type] => new
[patent_app_number] => 10/478879
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2815
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20040156844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478879
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478879 | Tamper resistant oral dosage form | Nov 19, 2003 | Abandoned |
Array
(
[id] => 7104990
[patent_doc_number] => 20050107295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Novel protein capable of inhibiting anthrax toxin activity'
[patent_app_type] => utility
[patent_app_number] => 10/715482
[patent_app_country] => US
[patent_app_date] => 2003-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4166
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107295.pdf
[firstpage_image] =>[orig_patent_app_number] => 10715482
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/715482 | Novel protein capable of inhibiting anthrax toxin activity | Nov 18, 2003 | Abandoned |
Array
(
[id] => 5636976
[patent_doc_number] => 20060067949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Immunization with porphyromonas gingivalis protects against heart disease'
[patent_app_type] => utility
[patent_app_number] => 10/535490
[patent_app_country] => US
[patent_app_date] => 2003-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6005
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20060067949.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535490
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535490 | Immunization with porphyromonas gingivalis protects against heart disease | Nov 17, 2003 | Abandoned |
Array
(
[id] => 8385931
[patent_doc_number] => 08263325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-11
[patent_title] => 'Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis'
[patent_app_type] => utility
[patent_app_number] => 10/712335
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7464
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10712335
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712335 | Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis | Nov 12, 2003 | Issued |
Array
(
[id] => 7100952
[patent_doc_number] => 20050103712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Methods and devices for treating severe peripheral bacterial infections'
[patent_app_type] => utility
[patent_app_number] => 10/712662
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3382
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20050103712.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712662
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712662 | Methods and devices for treating severe peripheral bacterial infections | Nov 12, 2003 | Abandoned |
Array
(
[id] => 6918040
[patent_doc_number] => 20050095601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Fluorescence polarization instruments and methods for detection of exposure to biological materials by fluorescence polarization immunoassay of saliva, oral or bodily fluids'
[patent_app_type] => utility
[patent_app_number] => 10/700868
[patent_app_country] => US
[patent_app_date] => 2003-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10351
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095601.pdf
[firstpage_image] =>[orig_patent_app_number] => 10700868
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/700868 | Fluorescence polarization instruments and methods for detection of exposure to biological materials by fluorescence polarization immunoassay of saliva, oral or bodily fluids | Nov 4, 2003 | Issued |
Array
(
[id] => 7343773
[patent_doc_number] => 20040191887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Botulinum neurotoxin B receptors and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/695577
[patent_app_country] => US
[patent_app_date] => 2003-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14809
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20040191887.pdf
[firstpage_image] =>[orig_patent_app_number] => 10695577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/695577 | Botulinum neurotoxin B receptors and use thereof | Oct 27, 2003 | Abandoned |
Array
(
[id] => 7374992
[patent_doc_number] => 20040219617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Enzymatic test for the determination of the risk of pathologies related to the presence of sialidase or prolidase activity in women body fluid samples'
[patent_app_type] => new
[patent_app_number] => 10/467357
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5160
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219617.pdf
[firstpage_image] =>[orig_patent_app_number] => 10467357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/467357 | Enzymatic test for the determination of the risk of pathologies related to the presence of sialidase or prolidase activity in women body fluid samples | Oct 19, 2003 | Abandoned |
Array
(
[id] => 7333275
[patent_doc_number] => 20040131620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Human polyclonal antibody compositions'
[patent_app_type] => new
[patent_app_number] => 10/475181
[patent_app_country] => US
[patent_app_date] => 2003-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13209
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20040131620.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475181
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475181 | Human polyclonal antibody compositions | Oct 16, 2003 | Abandoned |
Array
(
[id] => 5748625
[patent_doc_number] => 20060111557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Water soluble toxin produced by pfiesteria species'
[patent_app_type] => utility
[patent_app_number] => 10/530151
[patent_app_country] => US
[patent_app_date] => 2003-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2633
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111557.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530151
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530151 | Water soluble toxin produced by pfiesteria species | Oct 16, 2003 | Abandoned |
Array
(
[id] => 7323796
[patent_doc_number] => 20040137525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Detection of salmonella cells by fluorescence polarization'
[patent_app_type] => new
[patent_app_number] => 10/686053
[patent_app_country] => US
[patent_app_date] => 2003-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3840
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10686053
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/686053 | Detection of salmonella cells by fluorescence polarization | Oct 13, 2003 | Abandoned |
Array
(
[id] => 7380204
[patent_doc_number] => 20040081662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Vaccine'
[patent_app_type] => new
[patent_app_number] => 10/380563
[patent_app_country] => US
[patent_app_date] => 2003-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7953
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20040081662.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380563 | Vaccine | Oct 7, 2003 | Abandoned |
Array
(
[id] => 6911878
[patent_doc_number] => 20050175636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Transdermal patch for botulinum toxin administration'
[patent_app_type] => utility
[patent_app_number] => 10/675020
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11493
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175636.pdf
[firstpage_image] =>[orig_patent_app_number] => 10675020
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/675020 | Transdermal patch for botulinum toxin administration | Sep 28, 2003 | Abandoned |
Array
(
[id] => 7250367
[patent_doc_number] => 20050074461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Transdermal botulinum toxin compositions'
[patent_app_type] => utility
[patent_app_number] => 10/675172
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11494
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074461.pdf
[firstpage_image] =>[orig_patent_app_number] => 10675172
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/675172 | Transdermal botulinum toxin administration | Sep 28, 2003 | Issued |
Array
(
[id] => 7466430
[patent_doc_number] => 20040101947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Cell lysis composition, methods of use, apparatus and kit'
[patent_app_type] => new
[patent_app_number] => 10/673054
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25630
[patent_no_of_claims] => 121
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20040101947.pdf
[firstpage_image] =>[orig_patent_app_number] => 10673054
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/673054 | Cell lysis composition, methods of use, apparatus and kit | Sep 25, 2003 | Issued |
Array
(
[id] => 7380455
[patent_doc_number] => 20040081705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Digestion promoter for ruminant animal and breeding method of ruminant animal'
[patent_app_type] => new
[patent_app_number] => 10/663727
[patent_app_country] => US
[patent_app_date] => 2003-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2825
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20040081705.pdf
[firstpage_image] =>[orig_patent_app_number] => 10663727
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/663727 | Digestion promoter for ruminant animal and breeding method of ruminant animal | Sep 16, 2003 | Abandoned |
Array
(
[id] => 6991619
[patent_doc_number] => 20050090656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Cloning, sequencing and expresssion of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens'
[patent_app_type] => utility
[patent_app_number] => 10/662437
[patent_app_country] => US
[patent_app_date] => 2003-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 17780
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090656.pdf
[firstpage_image] =>[orig_patent_app_number] => 10662437
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/662437 | Cloning, sequencing and expresssion of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens | Sep 15, 2003 | Abandoned |
Array
(
[id] => 7097707
[patent_doc_number] => 20050130166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens'
[patent_app_type] => utility
[patent_app_number] => 10/662425
[patent_app_country] => US
[patent_app_date] => 2003-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 17784
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130166.pdf
[firstpage_image] =>[orig_patent_app_number] => 10662425
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/662425 | Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens | Sep 15, 2003 | Abandoned |
Array
(
[id] => 7390162
[patent_doc_number] => 20040037851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Fusobacterium necrophorum vaccine and method for making such vaccine'
[patent_app_type] => new
[patent_app_number] => 10/645643
[patent_app_country] => US
[patent_app_date] => 2003-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6418
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20040037851.pdf
[firstpage_image] =>[orig_patent_app_number] => 10645643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/645643 | Fusobacterium necrophorum vaccine and method for making such vaccine | Aug 20, 2003 | Abandoned |
Array
(
[id] => 7149892
[patent_doc_number] => 20040171121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Methods for preparing Bacillus anthracis sporulation deficient mutants and for producing recombinant Bacillus anthracis protective antigen for use in vaccines'
[patent_app_type] => new
[patent_app_number] => 10/638006
[patent_app_country] => US
[patent_app_date] => 2003-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12288
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171121.pdf
[firstpage_image] =>[orig_patent_app_number] => 10638006
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/638006 | Recombinant modified Bacillus anthracis protective antigen for use in vaccines | Aug 7, 2003 | Issued |